SPECIGEN INC.
SpeciGen is a developmental biotechnology company, engages in the design and development of protein cages that contain samples of cancer.
SPECIGEN INC.
Industry:
Biotechnology Therapeutics
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.specigen.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Nginx Baidu Analytics Energy Group Hosting
Similar Organizations
ArQule
ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company employs
Neumedicines
Neumedicines is a biotechnology company that focuses on the development of protein therapeutics.
Official Site Inspections
http://www.specigen.com
- Host name: 38.38.95.144
- IP address: 38.38.95.144
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "SpeciGen Inc."
SpeciGen Inc. - Crunchbase Company Profile & Funding
Organization. SpeciGen Inc. Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. SpeciGen is a developmental biotechnology company, …See details»
SpeciGen Company Profile | Management and Employees List
SpeciGen Profile and History SpeciGen is a dynamic and growing organization that seeks dedicated individuals committed to aggressive growth, scientific leadership and an …See details»
SpeciGen Inc. - Contacts, Employees, Board Members
SpeciGen is a developmental biotechnology company, engages in the design and development of protein cages that contain samples of cancer. Search Crunchbase. Start Free Trial . Chrome …See details»
SpeciGen - Products, Competitors, Financials, Employees, …
Use the CB Insights Platform to explore SpeciGen's full profile. SpeciGen - Products, Competitors, Financials, Employees, Headquarters Locations Technology VendorsSee details»
SpeciGen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore SpeciGen, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
New Montana Biotechnology Company, SpeciGen Launched, …
Dr. Bookbinder is the first CEO of SpeciGen and brings over 35 years of bio-pharmaceutical industry and executive experience to SpeciGen, an early stage drug development company. …See details»
Specigen, Inc. - CA, DE, MN, and MT - Bizapedia
SPECIGEN, INC. CALIFORNIA STOCK CORPORATION - OUT OF STATE - STOCK: WRITE REVIEW: Address: 329 Primrose Rd Ste 105 Burlingame, CA 94010: Registered Agent: Brian …See details»
SpeciGen - VentureRadar
SpeciGen VentureRadar profile. Find out more about SpeciGen, Nanotech.See details»
Marvin I. Siegel, Dir., Acting CEO, SpeciGen Corp.
Dr. Siegel (msiegel(at)specigen.com) has over 30 years of biopharmaceutical experience and is an executive with expertise in building companies, managing strategic alliances and …See details»
SpeciGen, Inc.:Board Members,Advisors,Employees,Team
Discovery Company profile page for SpeciGen, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
SpeciGen Management Team - CB Insights
Explore {SpeciGen's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. SpeciGen CEO, Founder, Key …See details»
SICGEN Company Profile - Office Locations, Competitors, Revenue …
See insights on SICGEN including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Precigen - Wikipedia
Precigen, Inc. (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company.Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is …See details»
Precigen Company Profile 2024: Stock Performance & Earnings
Information on stock, financials, earnings, subsidiaries, investors, and executives for Precigen. Use the PitchBook Platform to explore the full profile.See details»
Home - Precigen
1 2018 World Health Organization International Agency for Research on Cancer (IARC) Cancer Fact Sheet. Calculated from the WHO IARC global mortality statistic in the 2018 Cancer Fact …See details»
Precigen Completes Series Of Transactions To Solidify Healthcare …
Feb 3, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...See details»
Precigen Inc, PGEN:NSQ profile - FT.com - Financial Times
Nov 15, 2024 Precigen, Inc. is a dedicated discovery and clinical-stage biopharmaceutical company advancing gene and cell therapies. The Company’s proprietary technology platforms …See details»
Precigen, Inc. (PGEN) Company Profile & Overview - Stock Analysis
Nov 22, 2024 Precigen, Inc. operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases …See details»
Precigen Strategically Prioritizes Portfolio to Focus on First ...
Aug 6, 2024 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...See details»
About - Precigen
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent …See details»